With the largest install base of diagnostic instruments worldwide, we foster adoption of new therapies and help clinicians more quickly deliver on the promise of precision medicine. Our strong commercial presence in more than 100 countries and robust, decentralized affiliate network, translates to localized marketing and sales power that drives successful commercialization of your assay in key markets.
Launch & commercialization
Biomarker awareness
By activating early adopters, we gather real-world performance data to generate evidence that drives awareness and supports uptake. We also engage with payers and facilitate medical and sales training for our affiliates.
Day one readiness
We bridge the gap to ensure there is no delay in patient access to your therapy. We engage earlier with key opinion leaders and centers of excellence, prepare labs and deliver pathologist education to establish testing readiness.
Launch excellence and rapid adoption
Marketing and market access teams coordinate launches globally and locally, ensuring all critical tools for planning and execution of global launch strategy are available across Roche and pharma worldwide.
CASE STUDY
Bridging the path to CDx success
Find out how we enabled significant access to personalized therapy for cancer patients.
Our commercial strength is unmatched
Dominating market preference
Our traditional and accelerated commercialization models build awareness and drive adoption through a broad range of activities from pre-launch readiness to post-launch marketing.
Global affiliate activation
Guided by a global plan, regional Roche affiliates collaborate with local pharma to implement key commercialization activities.
Medical and commercial activities drive increased adoption
Our emphasis on evidence generation, pathologist training and education, and key opinion leader engagement leads to greater confidence in assay interpretation.